Table 1.
Topic | N = 642 | % Total | Dominant type |
% Topic |
---|---|---|---|---|
Genomics, general | 58 | 9% | Other normative | 40% |
Biorepository | 49 | 8% | Broader ELSI | 55% |
Genetics and race | 45 | 7% | Other normative | 47% |
Genetic enhancement | 44 | 7% | Ethics | 66% |
Genomic research and the public | 40 | 6% | Empirical | 60% |
Intellectual property | 38 | 6% | Other normative | 50% |
Personalized health interventions | 29 | 5% | Broader ELSI | 62% |
Genomics and clinical practice | 29 | 5% | Broader ELSI | 62% |
Human subject protection | 24 | 4% | Policy | 38% |
Informed consent | 24 | 4% | Empirical | 38% |
Broader ELSI | 38% | |||
Prenatal testing | 18 | 3% | Empirical | 44% |
Return of research results | 15 | 2% | Broader ELSI | 47% |
Gene transfer research | 14 | 2% | Broader ELSI | 71% |
GWAS or whole-genome sequencing | 13 | 2% | Broader ELSI | 69% |
Genomic research in native communities | 13 | 2% | Other normative | 54% |
Genomics and health disparities | 12 | 2% | Broader ELSI | 42% |
Newborn screening | 9 | 1% | Policy | 56% |
Genetic counseling | 9 | 1% | Broader ELSI | 55% |
Empirical | 45% | |||
Other genomic research | 49 | 8% | Broader ELSI | 45% |
Other genetic testing | 46 | 7% | Broader ELSI | 50% |
Other reproductive genetics | 24 | 4% | Broader ELSI | 33% |
Other normative | 33% | |||
Other | 40 | 6% | Broader ELSI | 48% |
ELSI, ethical, legal, and social implications; GWAS, genome-wide association study.